APA

Abe K., Yano T., Tanno M., Miki T., Kuno A., Sato T., Kouzu H., Nakata K., Ohwada W., Kimura Y., Sugawara H., Shibata S., Igaki Y., Ino S. & Miura T. (20200529). mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation. : Biochimica et biophysica acta. Molecular basis of disease.

Chicago

Abe Koki, Yano Toshiyuki, Tanno Masaya, Miki Takayuki, Kuno Atsushi, Sato Tatsuya, Kouzu Hidemichi, Nakata Kei, Ohwada Wataru, Kimura Yukishige, Sugawara Hirohito, Shibata Satoru, Igaki Yusuke, Ino Shoya and Miura Tetsuji. 20200529. mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation. : Biochimica et biophysica acta. Molecular basis of disease.

Harvard

Abe K., Yano T., Tanno M., Miki T., Kuno A., Sato T., Kouzu H., Nakata K., Ohwada W., Kimura Y., Sugawara H., Shibata S., Igaki Y., Ino S. and Miura T. (20200529). mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation. : Biochimica et biophysica acta. Molecular basis of disease.

MLA

Abe Koki, Yano Toshiyuki, Tanno Masaya, Miki Takayuki, Kuno Atsushi, Sato Tatsuya, Kouzu Hidemichi, Nakata Kei, Ohwada Wataru, Kimura Yukishige, Sugawara Hirohito, Shibata Satoru, Igaki Yusuke, Ino Shoya and Miura Tetsuji. mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation. : Biochimica et biophysica acta. Molecular basis of disease. 20200529.